PEACHTREE CANCER INSTITUTE Trademark

Trademark Overview


On Wednesday, September 21, 2022, a trademark application was filed for PEACHTREE CANCER INSTITUTE with the United States Patent and Trademark Office. The USPTO has given the PEACHTREE CANCER INSTITUTE trademark a serial number of 97600627. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, April 9, 2024. This trademark is owned by Piedmont Cancer Institute, P.C.. The PEACHTREE CANCER INSTITUTE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical services relating to cancer; Medical services, namely, for the diagnosis of cancer; Medical diagnosis and treatment of cancer, namely, the treatment of bladder cancer, brain cancer, breast cancer, colorectal cancer, esophageal cancer, endometrial cancer, ovarian cancer, kidney cancer, leukemia, liver cancer, lung cancer, lymphoma, melanoma, non-Hodgkin Lymphoma, pancreatic cancer, prostate cancer, sarcoma, and thyroid cancer; Medical diagnosis and treatment of hematological disorders; Clinical medical consulting services, namely, consulting on the treatment of cancer; Medical imaging services; Medical radiology services; Cancer screening services; Providing information in the field of cancer prevention, screening, diagnosis and treatment; Providing a website via a global computer network featuring information in the fields of cancer treatment, cancer recovery and survival
peachtree cancer institute

General Information


Serial Number97600627
Word MarkPEACHTREE CANCER INSTITUTE
Filing DateWednesday, September 21, 2022
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, April 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 13, 2024

Trademark Statements


Goods and ServicesMedical services relating to cancer; Medical services, namely, for the diagnosis of cancer; Medical diagnosis and treatment of cancer, namely, the treatment of bladder cancer, brain cancer, breast cancer, colorectal cancer, esophageal cancer, endometrial cancer, ovarian cancer, kidney cancer, leukemia, liver cancer, lung cancer, lymphoma, melanoma, non-Hodgkin Lymphoma, pancreatic cancer, prostate cancer, sarcoma, and thyroid cancer; Medical diagnosis and treatment of hematological disorders; Clinical medical consulting services, namely, consulting on the treatment of cancer; Medical imaging services; Medical radiology services; Cancer screening services; Providing information in the field of cancer prevention, screening, diagnosis and treatment; Providing a website via a global computer network featuring information in the fields of cancer treatment, cancer recovery and survival
Disclaimer with Predetermined Text"CANCER INSTITUTE"

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 6, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePiedmont Cancer Institute, P.C.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30318

Party NamePiedmont Cancer Institute, P.C.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30318

Trademark Events


Event DateEvent Description
Tuesday, April 9, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 13, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 13, 2024PUBLISHED FOR OPPOSITION
Wednesday, January 24, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 9, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, January 9, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 9, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, January 9, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, December 19, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 19, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 19, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 29, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, September 29, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, June 30, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 30, 2023NON-FINAL ACTION E-MAILED
Friday, June 30, 2023NON-FINAL ACTION WRITTEN
Friday, June 30, 2023ASSIGNED TO EXAMINER
Thursday, October 6, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 24, 2022NEW APPLICATION ENTERED